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Objective: To report a rare case of cervical malignancy necessitating complex treatment.
Case: A sixty-ﬁve year old woman was admitted to the hospital with a diagnosed tumor arising
from the upper lip of the cervix. Patient underwent the amputation of the cervix with the
curettage of the cervical channel. Because of the diagnosis of malignant mixed Mullerian tumor
(MMMT) a radical hysterectomy with pelvic lymphadenectomy was performed afterwards.
The composition of the tumor concerning basaloid carcinoma combined with homologous
sarcoma was published only in ﬁve cases in the known literature.
Conclusions: Because of rarity of MMMT there are no consensus guidelines regarding
treatment. We present the case with successful management and 4-year disease free survival.
& 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
About 80–90 % of cervical malignancies represent squamous cell
carcinomas followed by adenocarcinomas (10–20%) where inci-
dence is on the rise nowadays. Other types of tumors are
relatively rare. Malignant mixed Mullerian tumors of the cervix
are extremely rare (0.005% of all malignancies of the cervix).02.001
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43 4203 242.ﬁrst described in 1951 by Ferriera and colleagues [1,2]. MMMT´s
include both malignant epithelial and mesenchymal compo-
nents. The most common components are squamocellular
carcinoma combined with homologous sarcoma. So far only
about 50 cases can be found in the literature [3] and from these
only a smaller part was thoroughly described. Because of such a
number of cases there are no consensus guidelines regarding
treatment, prognosis and outcome.
2. Case report
A sixty-ﬁve year old woman (hypertensive, diabetic, P2) was
admitted to the hospital with a diagnosed tumor arising
from the upper lip of the cervix. She complained of three
months lasting intermittent vaginal bleeding one year afteren access article under the CC BY-NC-ND license
Fig. 1 PAP staining of the cytology sample from the site of
cervical tumor. Visible cells with morphologically large atypic
nuclei suspicious from malignity.
Fig. 2 (A–C) Haematoxilin staining of the tumor with emphasis
on the border of two different components (basaloid carcinoma
and homologous sarcoma).
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the vaginal examination at the Department an Exophytic
Fragile tumor 3 1.5 cm was conﬁrmed. The cytological
sample from the site of the tumor was suspicious from
malignity (Fig. 1). Patient underwent the amputation of the
cervix with the curettage of the cervical channel. Because
of the diagnosis of malignant mixed Mullerian tumor a
radical hysterectomy with pelvic lymphadenectomy was
performed afterwards. Subsequently whole pelvis irradia-
tion ( 60 Gy in 30 fractions) and cis-platin based adjuvant
chemotherapy were carried out without any complications.
The patient is now ﬁve years after the operation with no
signs of recurrence.
2.1. Pathological ﬁndings
Grossly the tumor occupied the anterior lip of the cervix with
regressive changes. Microscopically the tumor was composed
of two different parts. The epithelial part was composed of
basaloid squamocellular carcinoma (HMW CK+, EMA+)
whereas the mesenchymal part was represented by homo-
logous high-grade stromal sarcoma (CD 10+, vimentin+,
desmin+/, MSA, SMA, S100) (see Figs. 2 and 3) .
The endocervix was intact, without the inﬁltration, and
samples from the endocervical curettage were negative as
far as the malignancy was concerned. Uterus, fallopian tubes
and ovaries were intact. 30 Lymph nodes removed from the
iliac and obturatory regions were examined with no sign of
metastatic process. In conclusion the tumor was staged as
pT1bpN0pMx G3.
3. Discussion
MMMT of the cervix usually occurs in postmenopausal
women, although the age varies from 12 to 93 years [4,5].
Most of the patients complained of vaginal bleeding and had
a detectable mass in the uterine cervix. Grossly the cervical
tumors ranged between 1.1 and 10 cm [4]. Microscopically
the documented epithelial components of tumors were
represented by squamocellular carcinoma (keratinizing,non-keratinizing, basaloid, papillary) and adenocarcinoma.
Documented mesenchymal components were either
homologous or heterologous (rhabdomyosarcoma, chondro-
sarcoma). One case report described also neuroendocrine
component of MMMT. There are various etiologic factors
concerning radiation exposure to the pelvic area, previous
HMW CK CD 10
Vimentin
Fig. 3 Immunohistochemical ﬁndings. Positive CK staining in basaloid carcinoma (A), and positive vimentin and CD10 staining in
sarcomatous component (B, C).
Table 1 Literature review of basaloid MMMT's of the cervix (RT—radiotherapy, CHT—chemotherapy, TAH (total abdominal
hysterectomy), BSO (bilateral salpingo-oophorectomy), ACC—adenocarcinoma, SCC—squamocellular carcinoma, NA—not available).
Reference Age Presentation Treatment Carc. comp. Sarc. comp Outcome
[4] 71 Cervical mass Local excision,
RT+CHT
Basaloid carcinoma with
ACC like pattern
Low-grade myxoid ﬁbrosarcoma NA
[4] 70 Abnormal PAP TAH, BSO Basaloid carcinoma with
ACC like pattern
Low-grade myxoid ﬁbrosarcoma NA
[4] 87 Abnormal PAP Local excision, RT Basaloid carcinoma Homologous sarcoma NA
[6] 68 NA NA Basaloid carcinoma,
keratinizing SCC
Spindle cell sarcoma NA
[6] 55 NA NA Basaloid carcinoma Spindle/giant cell sarcoma NA
[6] 36 NA NA Basaloid carcinoma,
kratinising SCC
Spindle and myxoid cell sarcoma NA
[6] 93 NA NA Basaloid carcinoma,
kratinising SCC
Spindle/giant cell sarcoma NA
E. Kudela et al.14chemotherapy and HPV infection. The most common HPV
types detected in MMMTs are HPV 16 and 18. Grayson et al.
detected HPV16-DNA in the nuclei of both epithelial and
sarcomatous components in three cases. These observations
lend support to metaplastic theory of histogenesis [6].Our case represents only seventh documented case in the
literature of MMMT (according to the review of Khanna
et al.) composed of basaloid carcinoma and homologous
sarcoma (see Table 1). MMMTs of the cervix compared to
their counterparts in the corpus are more commonly
15Malignant mixed Mullerian tumor of the cervix – case reportconﬁned to the uterus at presentation and have a better
prognosis because of their early detection [4]. Behavior of
these tumors is dominated by the carcinomatous compo-
nent. Cervical MMMTs are according to a review article by
Khanna et al. managed with radical hysterectomy, che-
motherapy (cisplatin-based) and radiotherapy. According to
Table 1 appropriate data concerning treatment modalities
and outcome are missing in the literature. Some authors
advise the removal of pelvic and aortic lymph nodes,
omentectomy and peritoneal cytology in case of abdominal
dissemination. The role of adjuvant radiotherapy and
chemotherapy is also uncertain, but some authors have
shown the advantage of radiotherapy for disease-speciﬁc
survival in early stage tumors. Aggressive primary therapy
can result in curing early-stage tumors whereas extracervi-
cal disease has very poor prognosis [7]. Taxanes and
cisplatin-based chemotherapy, ifosfamid, along with pelvic
irradiation, may lead to increased survival in people with
metastatic carcinosaromas [8].
Median follow-up for patients with MMMTwas 16 months,
median time to death 10.5 months [9]. The follow-up of our
patient continues for 60 months (control every 6 months)
with negative ultrasound of small pelvis (every 6 moths),
negative oncocytology result and negative oncomarkers
(Ca125, CEA).
In summary, we present a case of MMMTof the cervix with
basaloid and high-grade homologous sarcoma components.
Despite its aggressive nature, the patient was successfully
managed with no signs of recurrence 5 years after the
surgery.
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